Detalles de la búsqueda
1.
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Genes Chromosomes Cancer
; 58(11): 815-819, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31340073
2.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267597
3.
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.
Genes Chromosomes Cancer
; 56(11): 810-820, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28758283
4.
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Ann Hematol
; 96(7): 1069-1075, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451802
5.
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Cancer
; 121(21): 3809-17, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26194343
6.
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy.
Blood
; 121(14): 2734-8, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23377436
7.
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
Haematologica
; 105(6): e294-e297, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537688
8.
Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older.
Eur J Haematol
; 95(6): 576-82, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25692738
9.
Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Cytotherapy
; 16(3): 406-11, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24176544
10.
Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Biol Blood Marrow Transplant
; 18(1): 100-5, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21703972
11.
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
Cancer
; 118(2): 410-7, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717435
12.
Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization.
Cytotherapy
; 14(7): 823-9, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22540329
13.
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
Haematologica
; 95(4): 589-96, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20145276
14.
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Transfus Apher Sci
; 43(3): 299-303, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20934383
15.
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis.
Oncol Ther
; 8(2): 311-324, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32700041
16.
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.
Oncotarget
; 9(27): 19342-19355, 2018 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721207
17.
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.
Leuk Lymphoma
; 59(7): 1634-1643, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29165013
18.
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Leuk Res
; 68: 79-84, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574396
19.
Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
Leuk Lymphoma
; 59(1): 146-154, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28554259
20.
Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
Leuk Lymphoma
; 57(1): 86-91, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25860236